FDA
-
-
-
-
-
-
-
New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted
-
-
-
-
-
-
-
Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc.
-
-
-
-
-
-
327,805 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

